Influenza virus-IN-10
Influenza virus-IN-10 is a dual-target antiviral agents for influenza that targets both PAC (KD = 8.9 μM) and NP (KD = 52.5 μM) simultaneously. Influenza virus-IN-10 exhibits an EC50 values of 1.64 μM) against influenza A virus (H1N1, A/WSN/33) and broad-spectrum activity against other influenza strains, including influenza B virus and multiple subtypes of influenza A[1].
Product Specifications
CAS Number
3031321-95-3
UNSPSC
12352005
Target
Influenza Virus
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C(C1=C(NC(CNC2=C(C)C=CC=C2)=O)C=CC=C1)NCCC3=C4C=CNC4=CC=C3
Molecular Formula
C26H26N4O2
Molecular Weight
426.51
References & Citations
[1]Zhang C, et al. Novel benzamide derivatives with indole moiety as dual-target antiviral agents: Rational design, efficient synthesis, and potent anti-influenza activity through concurrent binding to PAC terminal domain and viral nucleoprotein. Eur J Med Chem. 2025 Sep 5;293:117681.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941231-100 1x 100 µL
Eosinophil Peroxidase (AHE-1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401238-500 1x 500 µL
Napsin-A (NAPSA/1238), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881283-100 1x 100 µL
VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/1283), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details